ScoreWhy is Clearpoint Neuro, Inc. ?
1
Flat results in Jun 25
- INTEREST(9M) At USD 0.08 MM has Grown at inf%
- NET PROFIT(HY) At USD -11.86 MM has Grown at -38.68%
- ROCE(HY) Lowest at -85.68%
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 25.11%, its profits have fallen by -0.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Clearpoint Neuro, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Clearpoint Neuro, Inc.
17.17%
1.56
98.95%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
23.42%
EBIT Growth (5y)
-220.26%
EBIT to Interest (avg)
-16.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.82
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.60%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
19.70
EV to EBIT
-17.62
EV to EBITDA
-19.18
EV to Capital Employed
46.70
EV to Sales
11.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-265.08%
ROE (Latest)
-104.04%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET PROFIT(HY)
Higher at USD -11.86 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.86 times
NET SALES(Q)
Highest at USD 9.21 MM
-13What is not working for the Company
INTEREST(9M)
At USD 0.08 MM has Grown at inf%
NET PROFIT(HY)
At USD -11.86 MM has Grown at -38.68%
ROCE(HY)
Lowest at -85.68%
RAW MATERIAL COST(Y)
Grown by 5.11% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at -30.82 %
Here's what is working for Clearpoint Neuro, Inc.
Net Profit
Higher at USD -11.86 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 1.86 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at USD 9.21 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Here's what is not working for Clearpoint Neuro, Inc.
Interest
At USD 0.08 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Profit
At USD -11.86 MM has Grown at -38.68%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at -30.82 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
